A simple urine test could accurately detect recurring kidney cancer in patients recovering from surgery for the disease, potentially sparing them from frequent follow-up scans, researchers suggest.

GAGome score had 90 percent sensitivity, 51 percent specificity for radiological recurrence, with AUC of 0.73 for nonmetastatic clear-cell renal cell carcinoma.

There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.

Surgical removal of the tumor is a common first-line treatment. There are two types of kidney cancer surgery: Partial nephrectomy: The tumor and surrounding tissue are removed. Radical nephrectomy ...

Buccieri's experience not only deepened her appreciation for living in Lancaster, but for being part of the lacrosse coaching ...

Tony Jackson was already under anaesthetic, and his body had been cut open when the surgeon stopped. The retired soldier was ...

CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.

A new urine-based biomarker test could cut in half the need for surveillance imaging to detect recurrence of the most common ...

Last week, in an exclusive interview with The Today Show, retired NBA player Dwyane Wade revealed how he discovered his ...

In a groundbreaking medical milestone, Nigeria has become the first country in West Africa to successfully perform robotic ...

A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown ...